Figure 2, Manufacturer’s Reported Relative Risks and Alternative - Glycerol Phenylbutyrate (Ravicti)

From: APPENDIX 4, CLINICAL DATA USED IN REANALYSIS

Cover of Glycerol Phenylbutyrate (Ravicti)

Glycerol Phenylbutyrate (Ravicti) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Figure 2Manufacturer’s Reported Relative Risks and Alternative